These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 21800040)
1. The bleeding child. Part I: primary hemostatic disorders. van Ommen CH; Peters M Eur J Pediatr; 2012 Jan; 171(1):1-10. PubMed ID: 21800040 [TBL] [Abstract][Full Text] [Related]
2. Von Willebrand's disease: case report and review of literature. Echahdi H; El Hasbaoui B; El Khorassani M; Agadr A; Khattab M Pan Afr Med J; 2017; 27():147. PubMed ID: 28904675 [TBL] [Abstract][Full Text] [Related]
3. Effects of transcutaneous aortic valve implantation on aortic valve disease-related hemostatic disorders involving von Willebrand factor. Caspar T; Jesel L; Desprez D; Grunebaum L; Samet H; Trinh A; Petit-Eisenmann H; Kindo M; Ohlmann P; Morel O Can J Cardiol; 2015 Jun; 31(6):738-43. PubMed ID: 25935884 [TBL] [Abstract][Full Text] [Related]
4. Relative value of diagnostic studies for von Willebrand disease. Werner EJ; Abshire TC; Giroux DS; Tucker EL; Broxson EH J Pediatr; 1992 Jul; 121(1):34-8. PubMed ID: 1625090 [TBL] [Abstract][Full Text] [Related]
5. Diagnosis of von Willebrand's disease. A comparative study of diagnostic tests on nine families with von Willebrand's disease and its differential diagnosis from hemophilia and thrombocytopathy. Lian EC; Deykin D Am J Med; 1976 Mar; 60(3):344-56. PubMed ID: 1083143 [TBL] [Abstract][Full Text] [Related]
6. [Appropriate laboratory investigation in women with menorrhagia]. de Raucourt E; Ternisien C J Gynecol Obstet Biol Reprod (Paris); 2008 Dec; 37 Suppl 8():S317-28. PubMed ID: 19268209 [TBL] [Abstract][Full Text] [Related]
7. Clinical significance of inhibitors in acquired von Willebrand syndrome. Mohri H; Motomura S; Kanamori H; Matsuzaki M; Watanabe S; Maruta A; Kodama F; Okubo T Blood; 1998 May; 91(10):3623-9. PubMed ID: 9572997 [TBL] [Abstract][Full Text] [Related]
8. Inherited abnormalities of coagulation: hemophilia, von Willebrand disease, and beyond. Kumar R; Carcao M Pediatr Clin North Am; 2013 Dec; 60(6):1419-41. PubMed ID: 24237980 [TBL] [Abstract][Full Text] [Related]
9. Plasma and platelet von Willebrand factor abnormalities in patients with uremia: lack of correlation with uremic bleeding. Casonato A; Pontara E; Vertolli UP; Steffan A; Durante C; De Marco L; Sartorello F; Girolami A Clin Appl Thromb Hemost; 2001 Apr; 7(2):81-6. PubMed ID: 11292197 [TBL] [Abstract][Full Text] [Related]
10. High prevalence of bleeders of unknown cause among patients with inherited mucocutaneous bleeding. A prospective study of 280 patients and 299 controls. Quiroga T; Goycoolea M; Panes O; Aranda E; Martínez C; Belmont S; Muñoz B; Zúñiga P; Pereira J; Mezzano D Haematologica; 2007 Mar; 92(3):357-65. PubMed ID: 17339185 [TBL] [Abstract][Full Text] [Related]
11. The Montreal platelet syndrome kindred has type 2B von Willebrand disease with the VWF V1316M mutation. Jackson SC; Sinclair GD; Cloutier S; Duan Z; Rand ML; Poon MC Blood; 2009 Apr; 113(14):3348-51. PubMed ID: 19060241 [TBL] [Abstract][Full Text] [Related]
12. Anemia-Induced Bleeding in Patients with Platelet Disorders. Thakar S; Gabarin N; Gupta A; Radford M; Warkentin TE; Arnold DM Transfus Med Rev; 2021 Jul; 35(3):22-28. PubMed ID: 34332828 [TBL] [Abstract][Full Text] [Related]
13. How we make an accurate diagnosis of von Willebrand disease. Baronciani L; Peyvandi F Thromb Res; 2020 Dec; 196():579-589. PubMed ID: 31353031 [TBL] [Abstract][Full Text] [Related]
14. Absence of a bleeding tendency in severe acquired von Willebrand's disease. The role of platelet von Willebrand factor in maintaining normal hemostasis. Drouin J; Lillicrap DP; Izaguirre CA; Sutherland M; Windsor S; Benford K; Hoogendorn H; Giles AR Am J Clin Pathol; 1989 Oct; 92(4):471-8. PubMed ID: 2508465 [TBL] [Abstract][Full Text] [Related]
15. A novel von Willebrand factor mutation (I1372S) associated with type 2B-like von Willebrand disease: an elusive phenotype and a difficult diagnosis. Casonato A; Sartorello F; Pontara E; Gallinaro L; Bertomoro A; Grazia Cattini M; Daidone V; Szukowska M; Pagnan A Thromb Haemost; 2007 Dec; 98(6):1182-7. PubMed ID: 18064311 [TBL] [Abstract][Full Text] [Related]
16. Platelet von Willebrand factor determination does not improve the diagnosis of patients with suspected Type 1 von Willebrand disease. Shihong I; Morris D; Konkle BA Haemophilia; 2009 Jan; 15(1):131-4. PubMed ID: 18976254 [TBL] [Abstract][Full Text] [Related]
17. Clinical and molecular predictors of thrombocytopenia and risk of bleeding in patients with von Willebrand disease type 2B: a cohort study of 67 patients. Federici AB; Mannucci PM; Castaman G; Baronciani L; Bucciarelli P; Canciani MT; Pecci A; Lenting PJ; De Groot PG Blood; 2009 Jan; 113(3):526-34. PubMed ID: 18805962 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of abnormal bleeding in women. Kouides PA Curr Hematol Rep; 2002 Sep; 1(1):11-8. PubMed ID: 12901120 [TBL] [Abstract][Full Text] [Related]
19. Abnormalities of factor VIII and platelet aggregation--use of ristocetin in diagnosing the von Willebrand syndrome. Weiss HJ Blood; 1975 Mar; 45(3):403-12. PubMed ID: 1078779 [TBL] [Abstract][Full Text] [Related]
20. Review article: unexpected bleeding in the operating room: the role of acquired von Willebrand disease. Lison S; Dietrich W; Spannagl M Anesth Analg; 2012 Jan; 114(1):73-81. PubMed ID: 22025497 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]